Proton Advisory Council meets
Jerry D. Slater, MD (standing right), chair, department of radiation medicine, receives applause while sharing a positive update on proton treatment.
Wondering what’s happening in the proton therapy arena? That’s exactly why the Proton Advisory Council held a dinner on May 18—to share a news update.
“The main feature of the dinner,” explains Paul Arceneaux, major gifts officer, LLUMC, “was an overview on the progress of proton therapy and an update on the progress of ongoing cancer research made possible in part by members of the Proton Advisory Council and other former patients who fund cancer research through endowed chairs.”
There are four chairs dedicated to ongoing cancer research through the Proton Treatment Center: the James Slater Chair, the Ken Venturi Chair, the Del Webb Chair, and the Forresters Chair. Approximately $6.7 million of the $10 million goal has been raised to date for the funding of the endowed research chairs.
Other information presented at the dinner included how 60 percent of the proton treatments are for prostate cancer.
Traditional treatments such as surgery and radiation often cause impotence and incontinence. However, proton treatment virtually eliminates those side effects.
“We now have promising initial success with the study on the development of treatment for breast cancer,” says Mr. Arceneaux. “We are also investigating treatment for cancers of the liver and lung, and have experienced success with the treatment of cancers of the brain, the brain stem, and eye.”
For more information about the Proton Treatment Center you may visit <www.llu.edu/proton> or call (909) 558-4288.
By Patricia Thio